28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

Key Takeaways Explain This Topic AI

The TiTrATE diagnostic framework categorizes acute dizziness by Timing (episodic vs. continuous), Triggers (positional vs. spontaneous), and Targeted Examination, replacing the outdated and unreliable paradigm based on subjective descriptions ('vertigo vs. lightheadedness').

In patients with Continuous Vestibular Syndrome (acute continuous vertigo and nystagmus), the 3-step bedside HINTS examination (Head Impulse, Nystagmus, Test of Skew) is significantly more sensitive than diffusion-weighted brain MRI (DWI-MRI) within the first 24 to 48 hours for detecting cerebellar or brainstem ischemic stroke.

The INFARCT mnemonic predicts a central posterior fossa stroke: Impulse Normal (VOR intact), Fast-phase Alternating (direction-changing nystagmus on eccentric lateral gaze), and Refixation on Cover Test (vertical skew deviation); any single central sign mandates emergency stroke activation.

Benign Paroxysmal Positional Vertigo (BPPV) is caused by posterior canalithiasis, diagnosed by torsional upbeating nystagmus with 2-20 second latency on the Dix-Hallpike maneuver, and definitively cured by the Epley canalith repositioning maneuver (>85-90% success rate); vestibular suppressants (meclizine) are ineffective and not indicated.

Vestibular neuritis causes continuous severe vertigo, nausea, and unsteadiness with preserved auditory function, whereas labyrinthitis causes identical vestibular symptoms plus unilateral sensorineural hearing loss and tinnitus; vestibular suppressants (meclizine, diazepam) must be strictly restricted to the initial 48-72 hours to prevent blunting central neuroplastic compensation.

Last updated: September 2026

The Modern Approach to Acute Dizziness: The TiTrATE Framework

For decades, medical education taught clinicians to categorize dizziness by asking patients, 'What do you mean by dizzy?' and sorting responses into four distinct subjective silos: vertigo (spinning), presyncope (near-fainting), disequilibrium (imbalance), and lightheadedness (giddiness). Landmark clinical trials by Newman-Toker and colleagues demonstrated that this classical approach is fundamentally flawed, highly inaccurate, and clinically dangerous :

Over 50% of patients change their primary descriptive category when questioned multiple times within the same emergency encounter;

Patients frequently use 'spinning' to describe vasovagal presyncope, and 'lightheaded' to describe acute cerebellar stroke;

Reliance on subjective descriptions fails to distinguish benign peripheral vestibular conditions from fatal posterior circulation strokes.

The TiTrATE Diagnostic Paradigm

The modern, validated evidence-based approach is TiTrATE : categorizing dizziness by Timing , Triggers , And Targeted Examination : THE TiTrATE METHODOLOGY

• 1. TIMING 2. TRIGGERS
• ┌─────────────────────────────┐ ┌─────────────────────────────┐
• │ • Episodic (Seconds/Minutes)│ │ • Triggered (Positional/ │
• │ • Episodic (Hours) │ │ Orthostatic change) │
• │ • Continuous (Days/Weeks) │ │ • Spontaneous (No trigger) │
• └──────────────┬──────────────┘ └──────────────┬──────────────┘
• │ │
• └────────────────┬───────────────┘
• ▼
• 3. TARGETED EXAMINATION
• ┌───────────────────────────────────────────────────────────────┐
• │ • Positional Testing (Dix-Hallpike Maneuver) │
• │ • Oculomotor / Vestibulo-Ocular Reflex (HINTS Examination) │
• │ • Orthostatic Vital Signs & Cerebellar Motor Examination │
• └───────────────────────────────────────────────────────────────┘
• The Three Core Clinical Syndromes

Applying TiTrATE categorizes virtually every patient presenting with acute dizziness into one of three defined syndromes:

Clinical Syndrome Timing & Duration Primary Triggers Bedside Examination Findings Leading Differential Diagnoses

1. Acute Episodic Triggered Syndrome Brief paroxysms lasting seconds to <1 minute Specific physical triggers: head position change relative to gravity, or rising to standing Positive Dix-Hallpike maneuver (torsional upbeating nystagmus); or positive orthostatic vital sign drop Benign Paroxysmal Positional Vertigo (BPPV) ; Orthostatic hypotension; superior semicircular canal dehiscence (sound/pressure triggered)

2. Acute Episodic Spontaneous Syndrome Recurrent discrete spells lasting minutes to several hours None (spontaneous) ; occurs at rest without immediate movement trigger Examination during attack reveals spontaneous nystagmus; completely normal between episodes Meniere disease (20 min-12h + hearing loss/tinnitus); Vestibular migraine ; Vertebrobasilar TIA (transient cerebellar ischemia); Panic disorder

3. Acute Vestibular Syndrome (AVS) / Continuous Continuous, unremitting dizziness/vertigo lasting days to weeks Persistent at rest; exacerbated by (but not provoked by) head motion Spontaneous nystagmus, postural instability, nausea, vomiting, head motion intolerance Peripheral : Vestibular Neuritis, Labyrinthitis; Central : Cerebellar or Brainstem Ischemic Stroke (PICA/AICA)

The HINTS Examination: Differentiating Stroke from Vestibular Neuritis

Acute Vestibular Syndrome (AVS) represents an emergency diagnostic dilemma: distinguishing benign viral vestibular neuritis from a potentially fatal posterior circulation ischemic stroke (infarction of the cerebellum or brainstem, typically in the posterior inferior cerebellar artery [PICA] or anterior inferior cerebellar artery [AICA] territories).

The MRI Limitation vs. Bedside HINTS Accuracy

Diffusion-Weighted Brain MRI (DWI-MRI) has an alarming false-negative rate of 12% to 20% in the first 24 to 48 hours for small posterior fossa ischemic strokes. A normal emergency brain MRI performed within 24 hours of onset does NOT rule out a stroke!

The landmark HINTS to Diagnose Stroke in the Acute Vestibular Syndrome study (Kattah et al., Stroke 2009) demonstrated that a structured 3-component bedside oculomotor examination—the HINTS Exam (Head Impulse, Nystagmus, Test of Skew) —exhibits sensitivity of 100% and specificity of 96% for detecting stroke in acute AVS, outperforming early DWI-MRI!

CRITICAL CLINICAL PREREQUISITE : The HINTS examination is validated and clinically interpretable ONLY in patients with Continuous Vestibular Syndrome who have active, ongoing vertigo and observable spontaneous nystagmus . Performing HINTS on a patient with brief episodic dizziness (e.g., BPPV) or on a patient without nystagmus produces completely meaningless and dangerous results. THE THREE COMPONENTS OF HINTS

• 1. HEAD IMPULSE TEST (HIT) 2. NYSTAGMUS EVALUATION 3. TEST OF SKEW
• ────────────────────────── ─────────────────────── ───────────────
• Checks Vestibulo-Ocular Assesses Spontaneous & Assesses Graviceptive
• Reflex (VOR) Integrity Direction-Changing Gaze Vertical Alignment

• ABNORMAL HIT (Catch-up • UNIDIRECTIONAL (Beats one • NO SKEW (Eyes remain
• saccade back to nose): direction only; horizontal- conjugate upon alternate
• PERIPHERAL (Neuritis) torsional; fixed fast phase): covering): PERIPHERAL
• PERIPHERAL (Neuritis)
• NORMAL HIT (Gaze remains • SKEW DEVIATION (Vertical
• smoothly fixed on nose): • DIRECTION-CHANGING (Beats refixation saccade up

CENTRAL (Stroke!) right on right gaze, left on or down upon cover):

• left gaze; or pure vertical): CENTRAL (Stroke!)
• CENTRAL (Stroke!)
• Detailed Mechanics & Interpretation of HINTS Components
• 1. Head Impulse Test (HIT) of the Vestibulo-Ocular Reflex (VOR)

Technique : The examiner sits directly facing the patient, asking the patient to maintain continuous visual fixation on the examiner's nose. The examiner holds the patient's head firmly and delivers a rapid, unpredictable, small-amplitude (10° to 20°), high-acceleration horizontal head rotation to one side.

Peripheral Vestibular Lesion (Vestibular Neuritis) :

The unilateral peripheral vestibular end-organ or nerve is damaged; the VOR cannot drive compensatory eye movement.

When the head is rapidly turned toward the affected side, the patient's eyes move with the head (drifting away from the examiner's nose).

The patient must then make a noticeable corrective catch-up saccade back to the examiner's nose.

Exam Pearl : An ABNORMAL Head Impulse Test (presence of a catch-up saccade) indicates a PERIPHERAL vestibular nerve lesion.

Central Lesion (Posterior Circulation Ischemic Stroke) :

In isolated cerebellar strokes, the brainstem vestibulo-ocular reflex arc (vestibular nerve, vestibular nuclei, CN III/VI pathways) remains structurally intact.

The eyes remain locked smoothly on the examiner's nose throughout the head thrust without any catch-up saccade.

Exam Pearl : A NORMAL Head Impulse Test in a patient with acute continuous spinning vertigo indicates a CENTRAL STROKE !

2. Nystagmus Assessment (Spontaneous & Eccentric Gaze)

Peripheral Nystagmus (Vestibular Neuritis) :

Unidirectional : The fast phase beats in ONE single direction regardless of which direction the patient looks (beats away from the hypofunctioning lesion ear; fast phase toward the healthy, hyperactive contralateral ear).

Horizontal-torsional : Predominantly horizontal with a small torsional component; never pure vertical or pure torsional.

Alexander's Law : The nystagmus intensifies in amplitude and frequency when the patient looks in the direction of the fast phase.

Suppression with Visual Fixation : Nystagmus diminishes or disappears when the patient fixates on a visual target, and intensifies when fixation is removed (e.g., behind Frenzel lenses or during penlight examination).

Central Nystagmus (Posterior Fossa Stroke) :

Direction-Changing Nystagmus : The fast phase changes direction based on gaze: beats to the right on rightward gaze, and beats to the left on leftward gaze ( bidirectional gaze-evoked nystagmus ).

Pure Vertical or Pure Torsional Nystagmus : Downbeat nystagmus (strongly indicates craniocervical junction or cerebellar vermis lesion) or upbeat nystagmus (pontomedullary junction).

Failure to Suppress : Does not suppress with visual fixation.

3. Test of Skew (Alternate Cover Test)

Technique : The patient fixates straight ahead on the examiner's nose. The examiner alternately covers one eye and then the other in rapid succession, observing the newly uncovered eye for corrective vertical movement.

Peripheral Lesion : The eyes remain conjugate in the horizontal plane; no vertical shift occurs.

Central Lesion (Skew Deviation) :

Disruption of graviceptive pathways traversing the brainstem produces vertical ocular misalignment.

When the cover is shifted, the uncovered eye makes an immediate, visible vertical corrective saccadic refixation (one eye shifts downward to acquire the target, the other eye shifts upward).

Indicates a central brainstem or cerebellar lesion.

The INFARCT Central Stroke Rule

To synthesize the HINTS examination, remember the mnemonic INFARCT :

• I mpulse N ormal;
• F ast-phase A lternating (direction-changing);

R efixation on C over T est (skew deviation).

The Rule : If ANY SINGLE ONE of these three signs is central (Normal Head Impulse, Direction-Changing Nystagmus, OR Skew Deviation), the patient has a CENTRAL POSTERIOR CIRCULATION STROKE until proven otherwise! STAT emergency stroke activation, neurology consultation, and comprehensive neuroimaging are mandatory.

Additional Central Red Flags in Acute Vestibular Syndrome

Truncal Ataxia / Postural Instability Severity :

• Grade 1 (Mild) : Unsteady but walks unassisted (typical of peripheral neuritis);
• Grade 2 (Moderate) : Can sit unassisted, but requires support to walk;

Grade 3 (Severe) : Unable to sit upright in bed without support, falling immediately like a lead weight (pathognomonic for cerebellar stroke);

New Focal Neurological Signs : Dysarthria, dysphagia, facial numbness, limb dysmetria (finger-to-nose or heel-to-shin ataxia), or Horner syndrome (ptosis, miosis, anhidrosis in Wallenberg lateral medullary syndrome);

New Severe Occipital Headache or Posterior Neck Pain : Suggests vertebral artery dissection.

Benign Paroxysmal Positional Vertigo (BPPV)

Benign Paroxysmal Positional Vertigo (BPPV) is the single most common cause of peripheral vertigo in clinical practice, with a lifetime prevalence of 2.4%. It exhibits a female-to-male ratio of 2:1 and peaks in adults aged 50 to 70 years.

Pathophysiology: Canalithiasis vs. Cupulolithiasis

Canalithiasis (>90% of cases) : Calcium carbonate otoconia (otolith crystals) spontaneously detach from the macula of the utricle —due to degenerative aging, minor head trauma, or antecedent vestibular neuritis—and migrate into the semicircular canals.

The posterior semicircular canal is involved in 85% to 90% of cases , owing to its gravity-dependent, lowest anatomical position in the inner ear. (The horizontal/lateral canal is involved in 5% to 10%; the anterior/superior canal in <2%).

When the patient shifts the head relative to gravity, the free-floating, heavy otoconia debris moves within the canal like a piston, generating abnormal hydrodynamic endolymph flow that deflects the gelatinous cupula , sending false high-frequency acceleration signals to the brain.

Cupulolithiasis (<5-10%) : Otoconia adhere directly to the cupula itself, causing immediate, non-fatiguing positional vertigo.

Clinical Hallmarks

Brief, violent episodes of spinning vertigo lasting strictly less than 60 seconds (typically 15 to 30 seconds);

Triggered exclusively by changes in head position relative to gravity: rolling over in bed (the 'pillow turn'), tilting the head backward to look upward ('top-shelf vertigo'), or bending forward to tie shoes;

Patients are completely free of spinning vertigo when keeping the head stationary, though a vague, non-specific background sense of floating or imbalance may linger between spells;

Absence of cochlear symptoms (no hearing loss, no tinnitus) and absence of focal neurological deficits.

The Diagnostic Gold Standard: Dix-Hallpike Maneuver DIX-HALLPIKE MANEUVER PROTOCOL

1. Patient Seated Upright on Table

Turn head 45° toward the side being tested (e.g., right).

• │
• ▼
• 2. Rapidly Lower Patient Supine

Maintain 45° head turn; extend neck 20° over the table edge.

Eyes remain wide open, fixated on examiner's forehead.

• │
• ▼
• 3. Observe Eyes for 30 to 60 Seconds

Classic Positive Posterior Canal BPPV Response:

• Latency: 2 to 20 second delay before vertigo/nystagmus starts
• Torsional Upbeating Nystagmus: Top pole of eye beats TOWARD the
• lower affected ear, combined with vertical UPWARD beating
• Transient Duration: Resolves in <60 seconds (crescendo-decrescendo)
• Fatigability: Nystagmus diminishes with repeated maneuvers
• Reversal: Upright return provokes transient reverse nystagmus

If Dix-Hallpike testing produces pure horizontal nystagmus, the Supine Roll Test (Pagnini-McClure Test) is performed to evaluate for lateral (horizontal) semicircular canal BPPV .

Definitive Treatment: The Epley Maneuver (Canalith Repositioning)

The Epley maneuver uses sequential 90-degree head rotations to guide free-floating otoconia debris from the posterior semicircular canal, around the common crus, and back into the utricular vestibule, where the debris is safely resorbed by dark cells within days to weeks:

Step 1 : Perform Dix-Hallpike maneuver on the affected side (head turned 45°, extended 20°); hold position for 30 to 60 seconds (until nystagmus and vertigo subside);

Step 2 : Slowly rotate the head 90° toward the unaffected side (head now 45° toward opposite side, neck still extended); hold for 30 to 60 seconds;

Step 3 : Have the patient roll onto the shoulder of the unaffected side while turning the head another 90° in the same direction (patient's face is now angled 45° downward toward the floor); hold for 30 to 60 seconds;

Step 4 : While maintaining head-turned position, assist the patient into an upright seated position on the side of the table with chin tucked slightly forward.

Efficacy : Achieves >85% to 90% resolution of vertigo and nystagmus after just 1 or 2 treatment cycles !

Why Vestibular Suppressants (Meclizine) are Contraindicated in BPPV :

The AAO-HNS and American Academy of Neurology guidelines explicitly state that vestibular suppressant medications (meclizine, dimenhydrinate, benzodiazepines) are NOT recommended for BPPV ;

BPPV is a mechanical hydrodynamic disorder; medications do not reposition otoconia;

Antihistamines and benzodiazepines cause significant sedation, impair cognitive performance, increase fall risk in elderly patients, and blunts central adaptation.

Vestibular Neuritis and Labyrinthitis: Acute Stabilization & Compensation

Vestibular neuritis is an acute, self-limiting inflammatory disorder of the vestibular division of cranial nerve VIII, representing the second leading cause of peripheral vertigo (after BPPV).

Vestibular Neuritis vs. Labyrinthitis

Vestibular Neuritis : Inflammation is confined strictly to the superior division of the vestibular nerve . Manifests as sudden, severe, continuous spinning vertigo, nausea, vomiting, and gait ataxia. Cochlear function and hearing are ENTIRELY PRESERVED .

Labyrinthitis : Inflammation involves both the vestibular and cochlear branches of CN VIII or the membranous labyrinth itself. Manifests as identical continuous vertigo, nausea, and vomiting PLUS acute unilateral sensorineural hearing loss, roaring tinnitus, and aural fullness . PERIPHERAL AVS: NEURITIS vs. LABYRINTHITIS

• CLINICAL FEATURE VESTIBULAR NEURITIS LABYRINTHITIS
• ───────────────────────────────────────────────────────────────────
• Pathology Vestibular nerve alone Vestibular AND Cochlear
• Vertigo Duration Continuous (days) Continuous (days)
• Hearing Status 100% PRESERVED & NORMAL UNILATERAL SENSORINEURAL LOSS
• Tinnitus Absent Present (roaring/ringing)
• HINTS Exam Pattern Peripheral (Abnormal HIT, Peripheral (Abnormal HIT,
• Unidirectional Nystagmus) Unidirectional Nystagmus)
• Treatment Short-term suppressants, Short-term suppressants,
• Oral steroids, Early VRT High-dose steroids, Urgent ENT
• Medical Management: The 48-to-72-Hour Rule

Symptom Suppression (Acute Phase Only) :

In the first 24 to 48 hours, patients experience profound nausea, emesis, and incapacitating vertigo.

Appropriate agents: Antihistamines ( Meclizine 25 mg PO TID , Dimenhydrinate 50 mg), antiemetics ( Ondansetron 4-8 mg IV/PO , Promethazine), or low-dose benzodiazepines ( Diazepam 2-5 mg PO/IV ).

THE CRITICAL CLINICAL MANDATE : Vestibular suppressants must be STRICTLY DISCONTINUED AFTER 48 TO 72 HOURS !

Mechanism of Harm : The brain achieves clinical recovery from vestibular injury through central neuroplastic vestibular compensation (the cerebellum and vestibular nuclei actively recalibrate by comparing sensory asymmetry between the healthy and damaged sides). Vestibular suppressants sedate the central vestibular nuclei, blocking this recalibration. Prolonged use transforms an acute self-limiting condition into chronic persistent postural-perceptual dizziness (PPPD) , prolonged ataxia, and permanent unsteadiness.

Systemic Corticosteroids :

Oral methylprednisolone or prednisone (Prednisone 60-80 mg daily for 7 days followed by a 5-day taper) initiated within 3 days of symptom onset significantly accelerates peripheral vestibular recovery and reduces long-term caloric hypofunction.

Early Vestibular Rehabilitation Therapy (VRT) :

Specialized physical therapy employing vestibulo-ocular reflex (VOR) gaze stabilization exercises (fixating on a target while rotating the head horizontally and vertically, 'VOR x 1' and 'VOR x 2' exercises), habituation drills, and balance-gait retraining.

VRT should be initiated as soon as acute severe emesis abates (typically day 3 to 5), directly stimulating central neuroplastic compensation.

Loading diagram... Emergency Diagnostic Algorithm for Acute Dizziness & Vertigo